Form 4: Macrogenics Director Scott Thomas Jackson Reports Stock Transactions
SEC Form 4 Filing
Director Scott Thomas Jackson reports the vesting and disposal of 4,500 restricted stock units (RSUs) of Macrogenics Inc. on May 20, 2024.
Summary
- On May 20, 2024, Scott Thomas Jackson, a director of Macrogenics Inc., reported the vesting of 4,500 restricted stock units (RSUs).
- These RSUs were granted on May 31, 2023, and each RSU represents a contingent right to receive one share of Macrogenics Inc. common stock.
- The RSUs vested one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.
- Following the vesting, the 4,500 shares were disposed of.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company insider, and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the vesting of previously granted equity compensation.
Key Dates
| Date | Description |
|---|---|
| 05/31/2023 | The restricted stock unit (RSU) grant was approved by the Board of Directors. |
| 05/20/2024 | RSUs vested and were disposed of. |
| 05/21/2024 | Issuer's 2024 Annual Meeting of Stockholders. |
| 05/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.